Treating diseases at their biological source rather than managing symptoms forever
A chorus of pediatric researchers has charted the scientific horizons most likely to transform child health over the coming decade, naming ten domains—from genomics and mental health to cancer therapy and artificial intelligence—as fields ripe with possibility. Their mapping, drawn from the collective wisdom of sixty-six experts surveyed across 2025, is less a promise than a conditional one: the path from discovery to healing runs through sustained funding, a trustworthy relationship between science and the public, and a commitment to reaching every child, not only the fortunate few. In this, the report reads not merely as a scientific agenda but as a quiet moral reckoning with what society chooses to prioritize for its youngest members.
- Childhood diseases rooted in genetics may soon be treated at their biological source rather than managed symptom by symptom, as whole-genome sequencing and gene therapy edge closer to offering cures for conditions once considered lifelong.
- Rising rates of childhood anxiety and depression are pressing researchers to develop earlier, AI-assisted detection tools before mental health crises take hold in developing brains.
- Vaccine progress against COVID-19, RSV, and maternal illness is being quietly undermined by declining immunization rates and the return of diseases medicine had nearly eliminated.
- Artificial intelligence promises to personalize diagnosis and treatment across every frontier named, but experts warn it must be transparent, unbiased, and ethically governed before it can be trusted in clinical care.
- The entire agenda rests on a fragile foundation: eroding public confidence in science, uncertain research funding, and persistent inequities that ensure cutting-edge advances do not automatically reach all children.
A group of pediatric research leaders has published what amounts to a scientific map of the next decade in child health—ten interconnected domains they believe hold the greatest promise for transforming how children are diagnosed, treated, and protected. The findings, appearing in the journal Pediatric Research, emerged from a survey conducted between July and November of 2025, in which sixty-six faculty members drawn from major pediatric and academic medical organizations contributed nearly four hundred distinct ideas. Two large language models organized the responses into recurring themes, later confirmed by human review.
At the top of the list sits genomics and gene therapy, which experts see as tools capable of moving pediatric medicine away from managing symptoms toward addressing the biological roots of disease—offering, in some cases, the prospect of cure rather than chronic care. Close behind is mental health and neurodevelopment, where rising childhood anxiety and depression are driving demand for earlier diagnosis, individualized treatment, and AI tools that might identify vulnerable children before their struggles become severe.
Immunization stands as both a triumph and a warning. Advances against COVID-19, RSV, and maternal illness represent genuine progress, yet declining vaccination rates and the resurgence of preventable diseases reveal how quickly hard-won gains can unravel. Artificial intelligence appears as its own frontier, promising to integrate genetic, clinical, and environmental data into personalized care—though the experts stressed that such tools must be explainable and ethically governed to earn a place in clinical practice.
The remaining priorities span perinatal and neonatal medicine, precision therapeutics, health equity, childhood obesity and nutrition, environmental health, and pediatric oncology—a field transformed in recent years by CAR-T cell therapy, targeted treatments, and genomic profiling that have improved both survival and quality of life.
Yet the report's most insistent message is not about scientific possibility but about precondition. Every advance named depends on sustained research funding, a rebuilt public trust in science, a trained and supported workforce, and a genuine commitment to equitable implementation. The experts are not predicting breakthroughs. They are describing what breakthroughs would require.
A group of pediatric research leaders recently mapped out the scientific terrain they believe will reshape child health over the next decade. Their conclusion, published in the journal Pediatric Research, identifies ten interconnected areas of promise—from gene therapy and artificial intelligence to mental health care and cancer treatment—but comes with a crucial caveat: none of it happens without sustained funding, public trust, and a workforce equipped to carry the work forward.
The survey that produced these findings was straightforward in design. Between July and November of 2025, researchers reached out to members of the American Pediatric Society, pediatric department chairs from medical schools, and the American Academy of Pediatrics, asking them to identify the most promising research frontiers for child health and the priorities needed to advance them. Sixty-six faculty members responded with 192 distinct ideas about future research opportunities and 182 thoughts on what would help accelerate progress. Two large language models sorted through these responses to identify recurring themes, and a human reviewer confirmed the final categorization. What emerged were ten areas that appeared again and again in the experts' thinking.
Genomics and gene therapy topped the list. Researchers pointed to advances in whole-genome and whole-exome sequencing, along with gene-based therapies, as tools that could move pediatric medicine away from symptom management toward treating diseases at their biological root. For some lifelong conditions, these technologies might offer not just improvement but cure. Mental health and neurodevelopment ranked nearly as high. The experts flagged rising rates of childhood anxiety and depression, noting that early-life experiences shape brain development in ways that ripple across a person's entire future. They anticipated earlier diagnosis, individualized treatment plans, and artificial intelligence tools that could identify at-risk children before symptoms become severe.
Immunization and disease prevention have long been pediatric medicine's success story—vaccines have saved countless lives—yet the experts saw both achievement and peril in this space. The development of COVID-19 vaccines, new maternal immunization strategies, and protection against respiratory syncytial virus in infants represent genuine progress. But declining vaccination rates and the resurgence of preventable diseases underscore how fragile that progress can be. Artificial intelligence itself emerged as a distinct research frontier, with potential applications in diagnosis, risk prediction, treatment planning, and the integration of genetic, clinical, and environmental data for personalized medicine. The experts were careful to note, though, that AI tools need to be explainable, unbiased, and ethically governed if they are to fit into clinical practice without disrupting care.
Perinatal and neonatal health—including fetal medicine—represents another area of rapid advancement. New prenatal screening technologies, fetal surgery, and regenerative medicine are improving survival rates for high-risk births while shifting focus toward long-term neurodevelopment and thriving. Precision medicine and targeted therapeutics promise treatments tailored to individual genetic and biological characteristics. The experts also emphasized health equity and the social determinants of health: housing, education, income, nutrition, and access to care all shape whether a child thrives or struggles. Community-level interventions and policy changes, they argued, are essential to closing health disparities.
Obesity and nutrition emerged as areas ripe for innovation. New medications, including glucagon-like peptide-1 receptor agonists, have expanded the toolkit for managing childhood obesity, and personalized nutrition research may further improve outcomes. Environmental health research continues to clarify how air pollution, climate change, and chemical exposures affect child development and long-term health. Finally, pediatric oncology has seen remarkable progress through chimeric antigen receptor T-cell therapy, targeted treatments, and genomic profiling—advances that have improved both survival rates and quality of life for children with cancer.
The picture these ten areas paint is one of genuine scientific opportunity. Yet the experts were clear-eyed about what stands between possibility and reality. Sustained research funding is essential. Public trust in science, which has eroded in recent years, must be rebuilt. The workforce needs development and support. And all of these advances must be implemented equitably, reaching children across all communities, not just those with access to cutting-edge medical centers. The message is not that breakthroughs are inevitable. It is that they are possible—if the institutions and public will to support them are there.
Notable Quotes
These technologies may offer disease-modifying or curative approaches for some lifelong conditions— Pediatric research leaders on gene therapy and genomics
Long-term research funding, increased public confidence in science, workforce development, and continued support for pediatric research will be necessary— Study conclusion on requirements for progress
The Hearth Conversation Another angle on the story
Why did these researchers decide to map out the next decade of pediatric research right now?
Because the moment feels precarious. Pediatric medicine has a hundred-year track record of saving lives—vaccines, better infant care, cancer treatments that work. But funding is under pressure, public trust in science is declining, and the experts wanted to make the case for where investment should go next.
So this is partly advocacy?
It is. They're saying: here are the ten areas where breakthroughs are actually possible in the next five to ten years. But only if you fund them, only if people believe in the science, only if we have the people to do the work.
What surprised you most about the list?
That genomics and gene therapy are so clearly at the top. The idea that you could treat some diseases at their source rather than managing symptoms forever—that's a different kind of medicine than what we've had. But also that mental health ranked so high. Childhood anxiety and depression are rising, and the experts see AI and early identification as part of the answer.
There's a tension there, isn't there? Using AI to predict which children will develop mental health problems?
Absolutely. The experts acknowledged it. They want AI tools that are explainable and ethically governed. Not black boxes. Not tools that could deepen bias. The technology has to be trustworthy to be useful.
What about the social determinants piece—housing, education, income?
That's where the experts were most direct about what research alone cannot do. You can develop the best treatments in the world, but if a child doesn't have stable housing or enough food, those treatments won't reach their full potential. They're saying policy and community intervention matter as much as the science.
So what happens next?
That depends on whether the people with money and power believe this roadmap. The experts have done their part—they've identified where the science is heading. Now it's about whether institutions and governments will actually fund it.